Research programme: anti-fungal therapeutics - Shionogi/Nissan Chemical

Drug Profile

Research programme: anti-fungal therapeutics - Shionogi/Nissan Chemical

Latest Information Update: 03 Feb 2016

Price : $50

At a glance

  • Originator Nissan Chemical Industries; Shionogi
  • Class Antifungals; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Research Mycoses

Most Recent Events

  • 28 Jan 2016 Early research in Mycoses in Japan (unspecified route)
  • 28 Jan 2016 Shionogi and Nissan Chemical Industries agree to co-develop therapeutics for Mycoses
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top